Post by
gojotv! on Jun 07, 2021 4:08pm
If Grail's worth $8B, the superior ARISTOTLE is worth...???
How soon will investors figure out that StageZero is deployed, poised, and taking on the multi-cancer diagnostic blood test market?
June's a slow month, but success goes to the swift.
A gleeful GLTA smart SZLS investors!
Comment by
gojotv! on Jun 09, 2021 3:44pm
Grail doesn't even have Covid testing for travel, which makes you wonder about StageZero's ultra-undervalued market cap. Cheers!